The incidence of amyotrophic lateral sclerosis (ALS) and Parkinsonism-dementia complex 
Introduction
The island of Guam in the Western Pacific represents a geographic isolate with a striking incidence of fatal neurological diseases.1 Among them, the best known ailments are amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) which affected the native adult Chamorro population. The clinicopatho logical features of ALS are essentially identical to those observed in other populations of the world. ALS ac counted for 10% of the audlt death among Chamorros in the middle 1950's. A form of parkinsonism associated with progressive dementia termed "parkinsonism dementia complex" is also endemic in this population. 1 Neuropathologically PDC is characterized by severe neuronal loss affecting the cerebral cortex, especially the pyramidal neurons in the Ammon's horn and ad jacent temporal cortex, and brain stem nuclei, especially the substantia nigra and locus ceruleus.2 Widespread Alzheimer's neurofibrillary changes are prominent features in the remaining neurons in the central nervous system. The topographic distribution of the tangles is remarkable in that it affects certain specific neurons, while sparing others.3 The most vulnerale neurons are the pyramidal cells in the Sommer's sector, glomeruli of parahippocampal gyrus (entorhinal cortex), amygdaloid nucleus, anterior olfactory nucleus, nucleus basalis of Meynert, various hypothalamic nuclei, substantia nigra, periaqueductal gray, dorsal raphe nucleus, locus ceruleus, and the reticular formation of the brain stem. Some neurons, such as the large anterior horn cells in the spinal cord, are only rarely affected and some other neurons such as Purkinje cells and primary sensory neurons are spared from the Alzheimer's neurofibrillary changes. It is noteworthy that unlike Alzheimer's disease the neurofibrillary tangles are not associated with senile plaque formation in PDC on Guam. Alzheimer's neuro fibrillary changes are also observed in amyotrophic lateral sclerosis, although they are usually less extensive.3 The association of ALS and PDC is common and both disorders may occur in the same family. Although the etiology of ALS and PDC is still unknown, several hypothesis have been proposed.
During the past 20 years, the advent of immunohis tochemical methods has made possible the evaluation of normal and abnormal structures at the molecular level and the identification of pathological changes permitted the use of specific markers. Ammon's horn and entorhinal cortex are among the most severely affected areas of the brain in PDC and in Alzheimer's disease. The severe neuronal loss in Ammon's horn, especially Sommer's sector and subiculum is a characteristic feature of both diseases. A monoclonal antibody was used to visualize synapto physin, an integral component of presynaptic vesicle membranes. 4 We found a striking decrease of synapto physin expression in the areas with neuronal loss in PDC and Alzheimer's disease. Synaptophysin reactivity was also diminished in the molecular layer of the dentate gyrus in both diseases, with the inner portion showing an almost normal, and outer portion a sharply reduced immunoreactivity. The input to the outer portion of the molecular layer of the dentate gyrus originates mainly from the entorhinal cortex and the septohippocampal projections are additional important extrinsic afferents to this molecular layer. The loss of the synaptophysin immunoreactivity seen in the outer molecular layer of the dentate gyrus in both diseases may be the result of the involvement of the entorhinal cortex and the septum in these conditions.4 The significant loss of afferents in certain hippocampal areas could be related to the memory impairment seen in these disorders. It is worth while to emphasize that in spite of the absence of senile plaque formation in PDC, there is a remarkable similarity to Alzheimer's disease with respect to synaptophysin expression and distribution. 
Basal Ganglia and Substantia Nigra
The basal ganglia are well known regions involved in •~500.
Parkinson's disease, Huntington's disease, progressive supranuclear palsy, striatonigral degeneration and other extrapyramidal diseases. In contrast to certain entities, such as Huntington's disease and striatonigral degener ation which exhibit a distinct gross pathology of the basal ganglia, by using routine neuropathological staining methods no such striking basal ganglia alterations have been described in Parkinson's disease. However, the application of immunohistochemical procedures to the study of the basal ganglia and the substantia nigra pro vided importnat new infomation. Thus, the striatal pro jection neurons and their efferent fibers were analyzed with antibodies to calcineurin, Met-enkephalin and sub stance P.10 Tyrosine hydroxylase served as a marker for nigrostriatal dopaminergic neurons.10 The basal ganglia of patients with PDC reacted strongly with each antibody and in all instances a normal distribution pattern was seen.10 Furthermore, the striosomal organization was identified in Parkinson's disease" and in PDC12 (Fig 2) . These findings indicate that the striatal output system is well preserved in PDC patients. Similar findings were obtained in patients with Alzheimer's disease or Parkinson's disease. However, as compared to the patients with Alzheimer's or Parkinson's disease, the patients with PDC revealed a severe loss in the number of dopaminergic neurons in both, the medial and the lateral portions of the substantia nigra.10 In view of the functional corticosubcortical loops, these findings could explain, in part, the cognitive impairment and the Parkinsonian features that occur in PDC on Guam.
In patients with progressive supranuclear palsy, a severe depletion of substance P and Met-enkephalin-like immuno-reactivities was observed in the internal and One of our recent noteworthy findings pertains to Kcal deposits of ubiquitin in the anterior horn cells f the spinal cord of patients with ALS,15 both of the poradic and familial types and its absence in control idividuals. Ubiquitin deposits are also observed in Guam ALS. 16 Since Alzheimers neurofibrillary tangles are seen in he spinal cord of Guam ALS and PDC, we investigated au protein expression in the spinal cord in these patients. Vith the immunohistochemical technique employed we sere able to localize the neurofibrillary tangles (Fig 3) lore readily than by using conventional methods. 17 In ontrast to neurons in the lateral marginal areas of the osterior horn, only occasional Alzheimers neurofibril iry tangles were seen in large anterior horn cells. The eurofibrillary tangles are intracellular and are not my confined to soma, but are also found in neuronal rocesses similar to those in the cerebral cortex. The eurofibrillary tangles in the spinal cord were filaments omposed of around 15-nm-wide straight fibrils and few paired helical filaments with a periodicity of ap roximately 80nm.18 Alzheimers neurofibrillary tangles sere observed in all Guamanian ALS and PDC cases xamined, but none was seen in non Guamanian ALS.
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